PLRX
Price
$15.19
Change
-$0.00 (-0.00%)
Updated
Nov 7 closing price
116 days until earnings call
SPRY
Price
$16.14
Change
-$0.00 (-0.00%)
Updated
Nov 7 closing price
5 days until earnings call
Ad is loading...

PLRX vs SPRY

Header iconPLRX vs SPRY Comparison
Open Charts PLRX vs SPRYBanner chart's image
Pliant Therapeutics
Price$15.19
Change-$0.00 (-0.00%)
Volume$232.72K
CapitalizationN/A
ARS Pharmaceuticals
Price$16.14
Change-$0.00 (-0.00%)
Volume$588.44K
CapitalizationN/A
View a ticker or compare two or three
PLRX vs SPRY Comparison Chart
Loading...
PLRX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SPRY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
PLRX vs. SPRY commentary
Nov 09, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PLRX is a StrongSell and SPRY is a Buy.

COMPARISON
Comparison
Nov 09, 2024
Stock price -- (PLRX: $15.19 vs. SPRY: $16.14)
Brand notoriety: PLRX and SPRY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PLRX: 60% vs. SPRY: 63%
Market capitalization -- PLRX: $923.57M vs. SPRY: $1.52B
PLRX [@Biotechnology] is valued at $923.57M. SPRY’s [@Biotechnology] market capitalization is $1.52B. The market cap for tickers in the [@Biotechnology] industry ranges from $486.24B to $0. The average market capitalization across the [@Biotechnology] industry is $2.82B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PLRX’s FA Score shows that 0 FA rating(s) are green whileSPRY’s FA Score has 0 green FA rating(s).

  • PLRX’s FA Score: 0 green, 5 red.
  • SPRY’s FA Score: 0 green, 5 red.
According to our system of comparison, both PLRX and SPRY are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PLRX’s TA Score shows that 6 TA indicator(s) are bullish while SPRY’s TA Score has 4 bullish TA indicator(s).

  • PLRX’s TA Score: 6 bullish, 4 bearish.
  • SPRY’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, PLRX is a better buy in the short-term than SPRY.

Price Growth

PLRX (@Biotechnology) experienced а +7.96% price change this week, while SPRY (@Biotechnology) price change was +9.65% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.66%. For the same industry, the average monthly price growth was +14.64%, and the average quarterly price growth was +11.72%.

Reported Earning Dates

PLRX is expected to report earnings on Mar 04, 2025.

SPRY is expected to report earnings on Mar 20, 2025.

Industries' Descriptions

@Biotechnology (+3.66% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SPRY($1.65B) has a higher market cap than PLRX($913M). SPRY YTD gains are higher at: 194.526 vs. PLRX (-16.124). SPRY has higher annual earnings (EBITDA): -56.74M vs. PLRX (-181.41M). PLRX has more cash in the bank: 437M vs. SPRY (219M). SPRY has less debt than PLRX: SPRY (160K) vs PLRX (60.2M). SPRY has higher revenues than PLRX: SPRY (500K) vs PLRX (0).
PLRXSPRYPLRX / SPRY
Capitalization913M1.65B55%
EBITDA-181.41M-56.74M320%
Gain YTD-16.124194.526-8%
P/E RatioN/AN/A-
Revenue0500K-
Total Cash437M219M200%
Total Debt60.2M160K37,625%
TECHNICAL ANALYSIS
Technical Analysis
PLRXSPRY
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
82%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
76%
Momentum
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
72%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 2 days ago
85%
Declines
ODDS (%)
Bearish Trend 9 days ago
87%
Bearish Trend 15 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
83%
Aroon
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
PLRX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SPRY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FEAMX16.170.14
+0.87%
First Eagle Rising Dividend Fund C
FMFCX97.190.36
+0.37%
Fidelity Advisor Materials C
EPLIX23.58-0.08
-0.34%
NYLI Epoch U.S. Equity Yield Inv Class
RSOOX40.94-0.16
-0.39%
Columbia Dividend Opportunity R
WIFMX3.69-0.03
-0.81%
Wasatch Frontier Emerg Sm Countrs Instl

PLRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PLRX has been loosely correlated with NTLA. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if PLRX jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PLRX
1D Price
Change %
PLRX100%
-3.25%
NTLA - PLRX
54%
Loosely correlated
-0.37%
BEAM - PLRX
53%
Loosely correlated
-1.99%
PGEN - PLRX
50%
Loosely correlated
+6.29%
ABSI - PLRX
50%
Loosely correlated
-2.66%
PRME - PLRX
50%
Loosely correlated
N/A
More

SPRY and

Correlation & Price change

A.I.dvisor indicates that over the last year, SPRY has been loosely correlated with LPCN. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if SPRY jumps, then LPCN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SPRY
1D Price
Change %
SPRY100%
+2.67%
LPCN - SPRY
63%
Loosely correlated
-7.76%
INZY - SPRY
44%
Loosely correlated
-3.07%
ACLX - SPRY
42%
Loosely correlated
+6.65%
VIR - SPRY
39%
Loosely correlated
-3.93%
PLRX - SPRY
39%
Loosely correlated
-3.25%
More